Crohn Disease
UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers
Published in Medical Letter on the CDC and FDA, May 11th, 2008
UCB announced the launch of its CIMplicity(TM) program, designed to enhance treatment support for patients suffering from moderate to severe Crohn's disease. CIMplicity(TM) provides Cimzia(R) patients and their caregivers with comprehensive financial, administrative, compliance and treatment support. The U.S. Food and Drug Administration (FDA) approved Cimzia(R) for adult patients with moderate to severe Crohn's disease who have an inadequate response to conventional therapy on April 22, 2008.
"CIMplicity(TM) was developed by UCB to enhance the Crohn's patient experience by providing comprehensive treatment support to patients receiving Cimzia(R)," said David Robinson,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Biotechnology Business
Cephalon Notified of Generic Fentanyl Buccal Tablet Filing - Regulatory Actions
Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM) - Chemical Warfare
New findings from M.H. Boskabady and co-authors describe advances in chemical warfare - Contact Dermatitis
Researchers from Uppsala University publish new studies and findings in the area of contact dermatitis - Dengue Fever
Reports from University of New Mexico advance knowledge in dengue fever - Drug Resistance
Data on drug resistance reported by I.B. Sorokulova and co-researchers - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
